{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:25:15Z","timestamp":1785403515412,"version":"3.56.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council\u00a0of\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.bioorg.2019.103062","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T11:12:13Z","timestamp":1560337933000},"page":"103062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine and its bromo-derivative as dual cholinesterase inhibitors"],"prefix":"10.1016","volume":"90","author":[{"given":"Vijay K.","family":"Nuthakki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Mudududdla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip B.","family":"Bharate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103062_b0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bcp.2018.01.044","article-title":"Cholinesterases and the fine line between poison and remedy","volume":"153","author":"Pope","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103062_b0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5507\/bp.2011.036","article-title":"Cholinesterases, a target of pharmacology and toxicology","volume":"155","author":"Pohanka","year":"2011","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub."},{"key":"10.1016\/j.bioorg.2019.103062_b0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bioorg.2018.12.035","article-title":"Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and alpha-glycosidase inhibitors","volume":"85","author":"Burmaoglu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103062_b0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bioorg.2018.12.012","article-title":"The first synthesis, carbonic anhydrase inhibition and anticholinergic activities of some bromophenol derivatives with S including natural products","volume":"85","author":"Bayrak","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103062_b0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.bioorg.2018.12.028","article-title":"Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity","volume":"84","author":"Ozmen Ozgun","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103062_b0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145705005833","article-title":"Targeting acetylcholinesterase and butyrylcholinesterase in dementia","volume":"9","author":"Lane","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103062_b0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuint.2008.06.005","article-title":"Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease","volume":"53","author":"Pakaski","year":"2008","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.bioorg.2019.103062_b0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A review on cholinesterase inhibitors for Alzheimer's disease","volume":"36","author":"Anand","year":"2013","journal-title":"Arch. Pharm. Res."},{"issue":"4","key":"10.1016\/j.bioorg.2019.103062_b0045","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0011-393X(03)00059-6","article-title":"Cholinesterase inhibitors for the treatment of Alzheimer's disease: getting on and staying on","volume":"64","author":"Grossberg","year":"2003","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.bioorg.2019.103062_b0050","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejmech.2017.03.062","article-title":"Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease","volume":"132","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103062_b0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1155\/2014\/291214","article-title":"Dual binding site and selective acetylcholinesterase inhibitors derived from integrated pharmacophore models and sequential virtual screening","volume":"2014","author":"Gupta","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bioorg.2019.103062_b0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and tau hypothesis in alzheimer's disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"issue":"5580","key":"10.1016\/j.bioorg.2019.103062_b0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bioorg.2019.103062_b0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1567205012666141218140953","article-title":"Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease","volume":"12","author":"Baranello","year":"2015","journal-title":"Curr. Alzheimer Res."},{"issue":"4","key":"10.1016\/j.bioorg.2019.103062_b0075","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/dmd.104.002485","article-title":"Functional induction and de-induction of p-glycoprotein by st. John's wort and its ingredients in a human colon adenocarcinoma cell line","volume":"33","author":"Tian","year":"2005","journal-title":"Drug Metabol. Dispos."},{"issue":"6","key":"10.1016\/j.bioorg.2019.103062_b0080","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1021\/cn400024q","article-title":"Olive-oil-derived oleocanthal enhances \u03b2-amyloid clearance as a potential neuroprotective mechanism against Alzheimer\u2019s disease: In vitro and in vivo studies","volume":"4","author":"Abuznait","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103062_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.10.049","article-title":"Discovery of a marine-derived bis-indole alkaloid fascaplysin, as a new class of potent P-glycoprotein inducer and establishment of its structure-activity relationship","volume":"107","author":"Manda","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2019.103062_b0090","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1039\/C5OB00554J","article-title":"Synthesis and P-glycoprotein induction activity of colupulone analogs","volume":"13","author":"Bharate","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"32","key":"10.1016\/j.bioorg.2019.103062_b0095","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1039\/C4OB00488D","article-title":"Synthesis, and the antioxidant, neuroprotective and P-glycoprotein induction activity of 4-arylquinoline-2-carboxylates","volume":"12","author":"Bharate","year":"2014","journal-title":"Org. Biomol. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2019.103062_b0100","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1021\/acschemneuro.7b00101","article-title":"Crocus sativus extract tightens the blood-brain barrier, reduces amyloid beta load and related toxicity in 5XFAD mice","volume":"8","author":"Batarseh","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103062_b0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuint.2015.07.018","article-title":"Plant alkaloids as drug leads for Alzheimer's disease","volume":"89","author":"Ng","year":"2015","journal-title":"Neurochem. Int."},{"issue":"12","key":"10.1016\/j.bioorg.2019.103062_b0110","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/jphp.12090","article-title":"Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"65","author":"Konrath","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"issue":"9","key":"10.1016\/j.bioorg.2019.103062_b0115","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1039\/c2md20076g","article-title":"Total synthesis and anti-cholinesterase activity of marine-derived bis-indole alkaloid fascaplysin","volume":"3","author":"Bharate","year":"2012","journal-title":"MedChemComm"},{"issue":"8\u20139","key":"10.1016\/j.bioorg.2019.103062_b0120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.phymed.2009.10.008","article-title":"Pharmacological effects of Catharanthus roseus root alkaloids in acetylcholinesterase inhibition and cholinergic neurotransmission","volume":"17","author":"Pereira","year":"2010","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.bioorg.2019.103062_b0125","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1248\/bpb.27.1804","article-title":"Isolation of the acetylcholinesterase inhibitor ungeremine from Nerine bowdenii by preparative HPLC coupled on-line to a flow assay system","volume":"27","author":"Rhee","year":"2004","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.bioorg.2019.103062_b0130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1211\/jpp.58.6.0015","article-title":"Vobasinyl-iboga bisindole alkaloids, potent acetylcholinesterase inhibitors from Tabernaemontana divaricata root","volume":"58","author":"Ingkaninan","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103062_b0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-2006-957926","article-title":"Novel anticholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutaecarpa","volume":"62","author":"Park","year":"1996","journal-title":"Planta Med."},{"issue":"22","key":"10.1016\/j.bioorg.2019.103062_b0140","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.2174\/092986710791698521","article-title":"Indoloquinolines as scaffolds for drug discovery","volume":"17","author":"Lavrado","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103062_b0145","first-page":"627","article-title":"Sur la compesition chimnique de \u201cCryptolepis triangularis\u201d plante congolaise","volume":"12","author":"Clinquart","year":"1929","journal-title":"Bull. Acad. R. Med. Belg."},{"key":"10.1016\/j.bioorg.2019.103062_b0150","first-page":"955","article-title":"Sur la cryptolepine","volume":"13","author":"Delvaux","year":"1931","journal-title":"J. Pharm. Belg."},{"key":"10.1016\/j.bioorg.2019.103062_b0155","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/hlca.19510340228","article-title":"Die konstitution des alkaloids cryptolepin","volume":"34","author":"Gellert","year":"1951","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.bioorg.2019.103062_b0160","first-page":"2017","article-title":"Phytochemical and pharmacological review of Cryptolepis sanguinolenta (Lindl.) Schlechter","author":"Osafo","year":"2017","journal-title":"Adv. Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2019.103062_b0165","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1021\/jm040893w","article-title":"Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action","volume":"48","author":"Onyeibor","year":"2005","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103062_b0170","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0968-0896(01)00401-1","article-title":"Substituted indoloquinolines as new antifungal agents","volume":"10","author":"Ablordeppey","year":"2002","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103062_b0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-2008-1074902","article-title":"The alpha-adrenoceptor blocking properties of cryptolepine on the rat isolated vas deferens. Studies on cryptolepine","volume":"39","author":"Noamesi","year":"1980","journal-title":"Planta Med."},{"issue":"4","key":"10.1016\/j.bioorg.2019.103062_b0180","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.bmcl.2008.01.015","article-title":"Cryptolepine analogues containing basic aminoalkyl side-chains at C-11: synthesis, antiplasmodial activity, and cytotoxicity","volume":"18","author":"Lavrado","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103062_b0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.103062_b0190","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21544","article-title":"Identification of embelin, a 3-undecyl-1,4-benzoquinone from Embelia ribes as a multitargeted anti-Alzheimer agent","author":"Nuthakki","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2019.103062_b0195","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bioorg.2018.11.001","article-title":"Synthesis characterization, crystal structure of novel bis-thiomethylcyclohexanone derivatives and their inhibitory properties against some metabolic enzymes","volume":"82","author":"Bicer","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103062_b0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bioorg.2018.08.003","article-title":"Novel thymol bearing oxypropanolamine derivatives as potent some metabolic enzyme inhibitors - their antidiabetic, anticholinergic and antibacterial potentials","volume":"81","author":"Zengin","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2019.103062_b0205","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103062_b0210","doi-asserted-by":"crossref","first-page":"E2098","DOI":"10.3390\/molecules22122098","article-title":"Comparison of the binding of reversible inhibitors to human butyrylcholinesterase and acetylcholinesterase: A crystallographic, kinetic and calorimetric study","volume":"pii","author":"Rosenberry","year":"2017","journal-title":"Molecules 22(12)"},{"issue":"1","key":"10.1016\/j.bioorg.2019.103062_b0215","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1080\/14756366.2018.1476502","article-title":"Identification of new allosteric sites and modulators of AChE through computational and experimental tools","volume":"33","author":"Roca","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2019.103062_b0220","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1002\/chem.201203966","article-title":"Molecular recognition of rosmarinic acid from Salvia sclareoides extracts by acetylcholinesterase: a new binding site detected by NMR spectroscopy","volume":"19","author":"Marcelo","year":"2013","journal-title":"Chemistry"},{"issue":"15","key":"10.1016\/j.bioorg.2019.103062_b0225","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1021\/jm970735n","article-title":"Antihyperglycemic activities of cryptolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolenta","volume":"41","author":"Bierer","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103062_b0230","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1002\/cmdc.201800579","article-title":"Orally effective aminoalkyl 10H-indolo-[3,2-b]quinoline-11-carboxamide kills the malaria parasite by inhibiting host hemoglobin uptake","volume":"13","author":"Mudududdla","year":"2018","journal-title":"ChemMedChem"},{"issue":"10","key":"10.1016\/j.bioorg.2019.103062_b0235","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2174\/1567205013666160404120542","article-title":"Butyrylcholinesterase as a diagnostic and therapeutic target for Alzheimer's disease","volume":"13","author":"Darvesh","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bioorg.2019.103062_b0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: an important new target in Alzheimer's disease therapy","volume":"14","author":"Greig","year":"2002","journal-title":"Int. Psychogeriatr."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103062_b0245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1586\/14737175.5.1.101","article-title":"Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment","volume":"5","author":"Tasker","year":"2005","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bioorg.2019.103062_b0250","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","article-title":"Butyrylcholinesterase-knockout reduces brain deposition of fibrillar beta-amyloid in an Alzheimer mouse model","volume":"298","author":"Reid","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bioorg.2019.103062_b0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bioorg.2018.12.013","article-title":"Ursolic and oleanolic acid derivatives with cholinesterase inhibiting potential","volume":"85","author":"Loesche","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2019.103062_b0260","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1021\/acs.jmedchem.6b00356","article-title":"Discovery and structure-activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening","volume":"59","author":"Dighe","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103062_b0265","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ejmech.2016.11.056","article-title":"Amino derivatives of platanic acid act as selective and potent inhibitors of butyrylcholinesterase","volume":"126","author":"Heller","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103062_b0270","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0167-4838(94)90120-1","article-title":"Active-site peptides of acetylcholinesterase of Electrophorus electricus: labelling of His-440 by 1-bromo-[2-14C]pinacolone and Ser-200 by tritiated diisopropyl fluorophosphate","volume":"1208","author":"Salih","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2019.103062_b0275","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/105172399242573","article-title":"Purification and determination of the amino acid sequence of equine serum butyrylcholinesterase","volume":"9","author":"Moorad","year":"1999","journal-title":"Toxicol. Methods"},{"issue":"7","key":"10.1016\/j.bioorg.2019.103062_b0280","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800029","article-title":"meta-Cyanobenzyl substituted benzimidazolium salts: Synthesis, characterization, crystal structure and carbonic anhydrase, alpha-glycosidase, butyrylcholinesterase, and acetylcholinesterase inhibitory properties","volume":"351","author":"Turker","year":"2018","journal-title":"Arch. Pharm."},{"issue":"4","key":"10.1016\/j.bioorg.2019.103062_b0285","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22042","article-title":"Synthesis and discovery of potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase, and alpha-glycosidase enzymes inhibitors: The novel N, N'-bis-cyanomethylamine and alkoxymethylamine derivatives","volume":"32","author":"Taslimi","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2019.103062_b0290","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.molstruc.2018.11.038","article-title":"Imidazolinium chloride salts bearing wingtip groups: Synthesis, molecular docking and metabolic enzymes inhibition","volume":"1179","author":"Yi\u011fit","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2019.103062_b0295","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.poly.2018.11.048","article-title":"Novel morpholine liganded Pd-based N-heterocyclic carbene complexes: Synthesis, characterization, crystal structure, antidiabetic and anticholinergic properties","volume":"159","author":"Akta\u015f","year":"2019","journal-title":"Polyhedron"},{"issue":"48","key":"10.1016\/j.bioorg.2019.103062_b0300","doi-asserted-by":"crossref","first-page":"14642","DOI":"10.1021\/bi971425+","article-title":"Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase","volume":"36","author":"Saxena","year":"1997","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.bioorg.2019.103062_b0305","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1177\/0271678X15606463","article-title":"BACE-1 is expressed in the blood-brain barrier endothelium and is upregulated in a murine model of Alzheimer's disease","volume":"36","author":"Devraj","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"6","key":"10.1016\/j.bioorg.2019.103062_b0310","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/1567205013666161201201227","article-title":"Lack of p-glycoprotein results in impairment of removal of beta-amyloid and increased intraparenchymal cerebral amyloid angiopathy after active immunization in a transgenic mouse model of Alzheimer's disease","volume":"14","author":"Bruckmann","year":"2017","journal-title":"Curr. Alzheimer Res."},{"issue":"6","key":"10.1016\/j.bioorg.2019.103062_b0315","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2174\/1567205013666160314151012","article-title":"A role for p-glycoprotein in clearance of Alzheimer amyloid beta-peptide from the brain","volume":"13","author":"Wang","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bioorg.2019.103062_b0320","unstructured":"QikProp, version 4.4, Schr\u00f6dinger, LLC, New York, NY, 2015."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819303499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819303499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:50:41Z","timestamp":1758613841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819303499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":64,"alternative-id":["S0045206819303499"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103062","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine and its bromo-derivative as dual cholinesterase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103062"}}